Evidence map›Paper›PMID 41282155›Full record

ArticleResearch square2025

CHD3 and CHD4 coordinate gene expression programs to maintain β-cell function and identity

Sukrati Kanojia, Avinil Das Sharma, Rajani M George, Abigail G Taylor, Wenting Wu, Matthew T Dickerson, Spencer J Peachee, Prasanna K Dadi, Alexander Kacher, Harshith Devaguptapu and 7 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sukrati KanojiaDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Avinil Das SharmaDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0009-0001-6188-1038
Rajani M GeorgeCenter for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Abigail G TaylorDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Wenting WuDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
Matthew T DickersonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
Spencer J PeacheeDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
Prasanna K DadiDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0001-5377-5991
Alexander KacherDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0009-0007-1836-5509
Harshith DevaguptapuCenter for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Rebecca K DavidsonDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Snehasish NagCenter for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Kayla HuterCenter for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Meredith OsmulskiCenter for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Kassandra SandovalCenter for Diabetes & Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
David A JacobsonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0003-1816-5375
Jason M SpaethDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-1945-4323

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI David W Clapp · 1999 to 2026
$59.3M
Integrated Islet Distribution Program (U24) - 2021U24DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Carmella Evans-Molina, Joyce Carol Niland · 2021 to 2026
$17.8M
Translation CoreP30DK097512 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Tamara S Hannon · 2015 to 2026
$17.4M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and DysfunctionR01DK129340 · NIDDK · VANDERBILT UNIVERSITY · PI David Aaron Jacobson · 2022 to 2026
$2.3M
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetesR01DK136768 · NIDDK · VANDERBILT UNIVERSITY · PI David Aaron Jacobson · 2023 to 2026
$2.0M
The role of Pdx1-recruited Chd4:NuRD complex in controlling mature #-cell functionR01DK129287 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Jason M Spaeth · 2022 to 2026
$2.0M
Calcium Extrusion in the Context of Pancreatic Islet Function and DysfunctionR01DK144192 · NIDDK · VANDERBILT UNIVERSITY · PI David Aaron Jacobson · 2025 to 2026
$1.3M
NCI NIH HHS P30 CA082709NIDDK NIH HHS P30 DK097512NIDDK NIH HHS R01 DK129287NIDDK NIH HHS R01 DK129340NIDDK NIH HHS R01 DK136768NIDDK NIH HHS R01 DK144192NIDDK NIH HHS T32 DK007563NIDDK NIH HHS U24 DK098085NIDDK NIH HHS U54 DK106846
6 · The paper itself

Abstract

Pancreatic β cells require tightly regulated chromatin architecture to preserve their identity and sustain glucose-stimulated insulin secretion. Here, we define cooperative and compensatory roles for the NuRD complex remodelers CHD3 and CHD4 in maintaining β-cell function. While β-cell-specific loss of CHD3 alone had little effect, combined deletion of CHD3 and CHD4 caused severe glucose intolerance, impaired insulin secretion, and reduced β-cell area. Transcriptomic and chromatin accessibility analyses revealed downregulation of key β-cell maturity genes, reduced accessibility at β-cell enhancers, and derepression of disallowed, developmental, and alternative islet cell programs, accompanied by altered ion channel expression and defective electrophysiological properties. Mechanistically, CHD3 protein abundance increased upon CHD4 loss and CHD3:PDX1 interactions were dynamically enhanced during early high-fat diet challenge, buffering against β-cell stress before collapsing under chronic conditions. Human pseudoislets recapitulated conserved features of CHD3/4 deficiency, linking these remodelers to human β-cell function. Together, our findings establish CHD3 and CHD4 as cooperative guardians of β-cell transcriptional programs and uncover a compensatory mechanism that transiently preserves β-cell resilience under metabolic stress but fails in diabetes progression.

Indexed as

Beta CellCHD3CHD4CoregulatorInsulin SecretionSequencingType 2 Diabetes

Identifiers

PMID41282155
PMCPMC12637825

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.